{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:56:55Z","timestamp":1793383015890,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001634","name":"University of Galway","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001634","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.yexmp.2026.105045","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T13:30:15Z","timestamp":1776432615000},"page":"105045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Rebalancing inhibition: \u03b15 GABAA receptor positive and negative allosteric modulation in Alzheimer's disease"],"prefix":"10.1016","volume":"146","author":[{"given":"Aoife","family":"O'Connell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kwakowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2026.105045_bb0005","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3233\/JAD-215079","article-title":"Positive and negative selective allosteric modulators of \u03b15 GABAA receptors: effects on emotionality, motivation, and motor function in the 5xFAD model of Alzheimer\u2019s disease","volume":"84","author":"Aran\u0111elovi\u0107","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.yexmp.2026.105045_bb0010","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1111\/cns.13914","article-title":"Effects of \u03b15 GABA(A) receptor modulation on social interaction, memory, and neuroinflammation in a mouse model of Alzheimer\u2019s disease","volume":"28","author":"Aran\u0111elovi\u0107","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.yexmp.2026.105045_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pharmthera.2009.09.001","article-title":"Preclinical and clinical pharmacology of the GABAA receptor alpha5 subtype-selective inverse agonist alpha5IA","volume":"125","author":"Atack","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.yexmp.2026.105045_bb0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2006.02.055","article-title":"The proconvulsant effects of the GABAA \u03b15 subtype-selective compound RY-080 may not be \u03b15-mediated","volume":"548","author":"Atack","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yexmp.2026.105045_bb0025","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1124\/jpet.109.157636","article-title":"In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonist","volume":"331","author":"Atack","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yexmp.2026.105045_bb0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neurobiolaging.2024.12.001","article-title":"Procognitive and neurotrophic benefits of \u03b15-GABA-A receptor positive allosteric modulation in a \u03b2-amyloid deposition mouse model of Alzheimer\u2019s disease pathology","volume":"147","author":"Bernardo","year":"2025","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.yexmp.2026.105045_bb0035","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/alz.12088","article-title":"GABAergic dysfunction in excitatory and inhibitory (E\/I) imbalance drives the pathogenesis of Alzheimer\u2019s disease","volume":"16","author":"Bi","year":"2020","journal-title":"Alzheimer\u2019s Dementia"},{"key":"10.1016\/j.yexmp.2026.105045_bb0040","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/jnc.14345","article-title":"The GABAergic system as a therapeutic target for Alzheimer\u2019s disease","volume":"146","author":"Calvo-Flores Guzman","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.yexmp.2026.105045_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25030693","article-title":"Amyloid-beta(1-42) -induced increase in GABAergic tonic conductance in mouse hippocampal CA1 pyramidal cells","volume":"25","author":"Calvo-Flores Guzman","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.yexmp.2026.105045_bb0050","series-title":"\u03915-GABA-A Receptor Positive Allosteric Modulation Prevents Neuronal Atrophy and Cognitive Decline Independently of p-Tau Accumulation in the PS19 Mouse Model","author":"Dharavath","year":"2025"},{"key":"10.1016\/j.yexmp.2026.105045_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411788","article-title":"\u03915-GABAA receptor modulation reverses behavioral and neurophysiological correlates of psychosis in rats with ventral hippocampal Alzheimer\u2019s disease-like pathology","volume":"24","author":"Eassa","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexmp.2026.105045_bb0060","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.bbr.2018.07.013","article-title":"The \u03b15-GABA(A)R inverse agonist MRK-016 upregulates hippocampal BDNF expression and prevents cognitive deficits in LPS-treated mice, despite elevations in hippocampal a\u03b2","volume":"359","author":"Eimerbrink","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.yexmp.2026.105045_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081813","article-title":"Towards a better understanding of GABAergic remodeling in Alzheimer\u2019s disease","volume":"18","author":"Govindpani","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexmp.2026.105045_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27020883","article-title":"FDA-approved passive immunization treatments against a\u03b2 in Alzheimer\u2019s disease: where are we now?","volume":"27","author":"Higgins","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexmp.2026.105045_bb0075","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1124\/jpet.117.247627","article-title":"ONO-8590580, a novel GABA(A)\u03b15 negative allosteric modulator enhances long-term potentiation and improves cognitive deficits in preclinical models","volume":"366","author":"Kawaharada","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yexmp.2026.105045_bb0080","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/npp.2011.189","article-title":"GABAA receptor blockade enhances memory consolidation by increasing hippocampal BDNF levels","volume":"37","author":"Kim","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.yexmp.2026.105045_bb0085","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.4103\/1673-5374.235240","article-title":"Gamma-aminobutyric acid a receptors in Alzheimer\u2019s disease: highly localized remodeling of a complex and diverse signaling pathway","volume":"13","author":"Kwakowsky","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.yexmp.2026.105045_bb0090","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.4103\/1673-5374.300987","article-title":"Therapeutic potential of alpha 5 subunit containing GABA(A) receptors in Alzheimer\u2019s disease","volume":"16","author":"Kwakowsky","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.yexmp.2026.105045_bb0095","series-title":"The \u03b2-amyloid-induced Increased Tonic Conductance, Impaired Long-term Potentiation and Cognitive Deficits Characteristic of Alzheimer\u2019s Disease are Reversed by an \u03b15 Inverse Agonist of a GABA Type a Receptor","author":"O\u2019Connell","year":"2026"},{"key":"10.1016\/j.yexmp.2026.105045_bb0100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12017-009-8097-7","article-title":"Synaptic depression and aberrant excitatory network activity in Alzheimer\u2019s disease: two faces of the same coin?","volume":"12","author":"Palop","year":"2010","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.yexmp.2026.105045_bb0105","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrn.2016.141","article-title":"Network abnormalities and interneuron dysfunction in Alzheimer disease","volume":"17","author":"Palop","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.yexmp.2026.105045_bb0110","article-title":"Selective modulation of \u03b15 GABAA receptors exacerbates aberrant inhibition at key hippocampal neuronal circuits in APP mouse model of Alzheimer\u2019s disease","volume":"14-2020","author":"Petrache","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.yexmp.2026.105045_bb0115","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer\u2019s disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.yexmp.2026.105045_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27175481","article-title":"Lipopolysaccharide-induced model of neuroinflammation: mechanisms of action, research application and future directions for its use","volume":"27","author":"Skrzypczak-Wiercioch","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.yexmp.2026.105045_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093284","article-title":"An 5 GABAA receptor inverse agonist, 5IA, attenuates amyloid Beta-induced neuronal death in mouse hippocampal cultures","volume":"21","author":"Vinnakota","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexmp.2026.105045_bb0130","article-title":"Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzhiemer\u2019 s disease model","volume":"5","author":"Wu","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexmp.2026.105045_bb0135","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00213-018-4832-9","article-title":"Negative allosteric modulation of alpha 5-containing GABA(A) receptors engenders antidepressant-like effects and selectively prevents age-associated hyperactivity in tau-depositing mice","volume":"235","author":"Xu","year":"2018","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480026000249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480026000249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T08:22:27Z","timestamp":1781684547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480026000249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":27,"alternative-id":["S0014480026000249"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2026.105045","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rebalancing inhibition: \u03b15 GABAA receptor positive and negative allosteric modulation in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2026.105045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105045"}}